Home
Conditions
Burkitt Lymphoma

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Recruiting

Gut Health in Children With Cancer

NCT06899581

Conditions: AML (Acute Myelogenous Leukemia, Burkitt Lymphoma, Burkitt Lymphoma/Leukemia, +21 more
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Recruiting

Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia

NCT06581081

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +22 more
Locations: Peking University People'S Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

NCT06060782

Conditions: Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations: The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China

View Trial Details

Recruiting

Immunotherapy in Lymphoma

NCT06796517

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
Locations: Seoul St. Mary Hospital Seoul, South Korea

Yeoido St. Mary Hospital Seoul, South Korea

View Trial Details

Recruiting

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

NCT06793241

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

NCT06179524

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: Hematology Hospital of the Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05281809

Conditions: B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
Locations: AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

NCT05054257

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +23 more
Locations: Institute of Hematology and Blood Transfusion, Czech Republic Prague, Czechia

View Trial Details

Recruiting

CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors

NCT06735495

Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

NCT06696833

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, China, Jiangsu, China

View Trial Details

Burkitt Lymphoma

Burkitt Lymphoma trial results

Related conditions